Loke, Yoon K.

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ

Meta-analysis and systematic reviewsAdvanced Causal Inference Techniques

Cited by 20,329

PRISMA harms checklist: improving harms reporting in systematic reviews

Zorzela, L., Loke, Y. K., Ioannidis, J. P., Golder, S., Santaguida, P., Altman, D. G., Moher, D., Vohra, S., & PRISMA harms group (2016) · BMJ

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 557

Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis

Gorst, C., Kwok, C. S., Aslam, S., Buchan, I., Kontopantelis, E., Myint, P. K., Heatlie, G., Loke, Y., Rutter, M. K., & Mamas, M. A. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 530

Anticholinergic drugs and risk of dementia: case-control study

Richardson, K., Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., et al. (2018) · BMJ

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 520

Self-reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis

Kwok, C. S., Kontopantelis, E., Kuligowski, G., Gray, M., Muhyaldeen, A., Gale, C. P., Peat, G. M., Cleator, J., Chew‐Graham, C., Loke, Y. K., et al. (2018) · Journal of the American Heart Association

Sleep and related disordersSleep and Work-Related Fatigue

Cited by 506

Association of Obstructive Sleep Apnea With Risk of Serious Cardiovascular Events: A Systematic Review and Meta-Analysis

Loke, Y. K., Brown, J. W. L., Kwok, C. S., Niruban, A., & Myint, P. K. (2012) · Circulation: Cardiovascular Quality and Outcomes

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 367

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

Singh, S., Loke, Y. K., Spangler, J. G., & Furberg, C. D. (2011) · Canadian Medical Association Journal

Smoking Behavior and CessationPharmacovigilance and Adverse Drug Reactions

Cited by 286

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

Junqueira, D. R., Zorzela, L., Golder, S., Loke, Y., Gagnier, J. J., Julious, S. A., Li, T., Mayo-Wilson, E., Pham, B., Phillips, R., et al. (2023) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 281

Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review

Golder, S., Loke, Y. K., Wright, K., & Norman, G. (2016) · PLOS Medicine

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 277

Thiazolidinediones and Heart Failure

Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · Diabetes Care

Diabetes Treatment and ManagementPharmacovigilance and Adverse Drug Reactions

Cited by 262

Systematic reviews of adverse effects: framework for a structured approach

Loke, Y. K., Price, D., Herxheimer, A., & the Cochrane Adverse Effects Methods Group (2007) · BMC Medical Research Methodology

Meta-analysis and systematic reviewsPharmacovigilance and Adverse Drug Reactions

Cited by 253

Quality of reporting in systematic reviews of adverse events: systematic review

Zorzela, L., Golder, S., Liu, Y., Pilkington, K., Hartling, L., Joffe, A., Loke, Y., & Vohra, S. (2014) · BMJ

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 217

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews

Saini, P., Loke, Y. K., Gamble, C., Altman, D. G., Williamson, P. R., & Kirkham, J. J. (2014) · BMJ

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 209

Vegetarian diet, Seventh Day Adventists and risk of cardiovascular mortality: a systematic review and meta-analysis

Kwok, C. S., Umar, S., Myint, P. K., Mamas, M. A., & Loke, Y. K. (2014) · International Journal of Cardiology

Nutritional Studies and DietAgriculture Sustainability and Environmental Impact

Cited by 205

Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies

Song, F., Parekh-Bhurke, S., Hooper, L., Loke, Y. K., Ryder, J. J., Sutton, A. J., Hing, C. B., & Harvey, I. (2009) · BMC Medical Research Methodology

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 175

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis

Pieper, N. T., Grossi, C. M., Chan, W.-Y., Loke, Y. K., Savva, G. M., Haroulis, C., Steel, N., Fox, C., Maidment, I. D., Arthur, A. J., et al. (2020) · Age and Ageing

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 138

Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study

Xu, C., Yu, T., Furuya-Kanamori, L., Lin, L., Zorzela, L., Zhou, X., Dai, H., Loke, Y., & Vohra, S. (2022) · BMJ

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 82

Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study

Richardson, K., Loke, Y. K., Fox, C., Maidment, I., Howard, R., Steel, N., Arthur, A., Boyd, P. J., Aldus, C., Ballard, C., et al. (2020) · BMC Medicine

Pharmaceutical Practices and Patient OutcomesSleep and related disorders

Cited by 73

Meta-analysis: Association between hypoglycemia and serious adverse events in older patients treated with glucose-lowering agents

Mattishent, K., & Loke, Y. K. (2021) · Frontiers in Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 69

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials

Junqueira, D. R., Zorzela, L., Golder, S., Loke, Y., Gagnier, J. J., Julious, S. A., Li, T., Mayo-Wilson, E., Pham, B., Phillips, R., et al. (2023) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 67

Issues relating to selective reporting when including non‐randomized studies in systematic reviews on the effects of healthcare interventions

Norris, S. L., Moher, D., Reeves, B. C., Shea, B., Loke, Y., Garner, S., Anderson, L., Tugwell, P., & Wells, G. (2013) · Research Synthesis Methods

Meta-analysis and systematic reviewsAdvanced Causal Inference Techniques

Cited by 50

Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources

Loke, Y. K., Golder, S. P., & Vandenbroucke, J. P. (2011) · Therapeutic Advances in Drug Safety

Meta-analysis and systematic reviewsPharmacovigilance and Adverse Drug Reactions

Cited by 49

Volatile organic compounds associated with diagnosis and disease characteristics in asthma – A systematic review

Peel, A. M., Wilkinson, M., Sinha, A., Loke, Y. K., Fowler, S. J., & Wilson, A. M. (2020) · Respiratory Medicine

Advanced Chemical Sensor TechnologiesAsthma and respiratory diseases

Cited by 40

Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study

Xu, C., Fan, S., Tian, Y., Liu, F., Furuya-Kanamori, L., Clark, J., Zhang, C., Li, S., Lin, L., Chu, H., et al. (2025) · BMJ

Meta-analysis and systematic reviewsAcademic integrity and plagiarism

Cited by 39